Africa stands at a critical crossroads in its healthcare and pharmaceutical evolution. With a population exceeding 1.4 billion and projected to reach 2.5 billion by 2050, the continent presents both a profound challenge and an extraordinary opportunity in the global health ecosystem. For decades, the pharmaceutical landscape in Africa has been characterized by heavy reliance on imported drugs, with over 70–90 per cent of medicines sourced from international markets such as India, China, and Europe.